It is proposed that CtBP1 or CtBP2 knockdown induce apoptosis in serous ovarian cancer cells, and that CtBP1/2-DKD accelerate the process of apoptosis while failing to generate stable double knockdown cells. Here, CTBP2 is linked to ovarian serous adenocarcinoma.